Connect with us

Media OutReach

Spackman Entertainment Group’s Korean Remake of The Taiwanese Hit YOU ARE THE APPLE OF MY EYE, Produced by Studio Take, Premieres Today in Korea, Ranking #1 In Advance Ticket Reservation Sales for Korean Films

Published

on

  • Produced by the Group’s wholly-owned indirect subsidiary, Studio Take, the Korean adaptation of the Taiwanese hit YOU ARE THE APPLE OF MY EYE, premieres today, topping advance ticket reservation sales for Korean films
  • Following Studio Take’s A MAN OF REASON (2023), which premiered globally at the 47th Toronto International Film Festival, the addition of YOU ARE THE APPLE OF MY EYE to its portfolio underscores Studio Take’s capability in delivering top quality content

SINGAPORE – Media OutReach Newswire – 21 February 2025 – Spackman Entertainment Group Limited (the “Group“), one of Korea’s leading entertainment production groups founded in 2011 by global media & technology investor Charles Spackman, wishes to announce that the Group’s Korean film adaptation of the Taiwanese hit YOU ARE THE APPLE OF MY EYE, produced by the Group’s wholly‐owned indirect subsidiary, Studio Take Co., Ltd. (“Studio Take“), premieres today at the Korean theatres, ranking #1 in advance ticket reservation sales for Korean films.

According to the Korean Film Council, Studio Take’s film remake of YOU ARE THE APPLE OF MY EYE recorded 8.8% of the advance ticket reservation market with an estimated total of KRW 250 million (USD 174,260[1]) in advance sales.[2]

The coming of age romance film relates the story of a group of friends who attend the same high school, having a crush on the same girl.

Spackman Equities Group Inc. (TSXV: SQG), which is listed on the TSX Venture Exchange in Canada, is one of the major investors of the film.

The 2011 original work of YOU ARE THE APPLE OF MY EYE became a breakout hit in Taiwan, Hong Kong and Singapore for Taiwanese novelist and filmmaker, Giddens Ko, and Taiwanese actor, Kai Ko. The Taiwanese film enjoyed huge box office success even in Korea with an average review score of 9.14 on Naver Movie. Subsequently, a Japanese film remake of the same name directed by Yasuo Hasegawa, was released in 2018.

The Korean remake of YOU ARE THE APPLE OF MY EYE is produced by Studio Take’s Song Dae-chan, whose track record comprises A MAN OF REASON (2023), which premiered globally at the 47th Toronto International Film Festival, BROKER (2022), which was selected to compete for the Palme d’Or at the 2022 Cannes Film Festival, musical film THE BOX, which opened #1 at the Korean box office on the first day of its wide release, and art film STONE SKIPPING (2020), which was screened at the 23rd Busan International Film Festival. The Korean romantic film marks the directorial debut of Cho Young-myoung and stars Jung Jin-young, who is a former leader of boy group B1A4 and known for his acting in K-dramas POLICE UNIVERSITY (2021) and LOVE IN THE MOONLIGHT (2016), and Dahyun, who is a member of girl group TWICE, one of the most successful K-pop groups of all time, and a global ambassador for the brand Michael Kors.

Son Jeong-Hyuk of MSteam Entertainment Co., Ltd., a wholly-owned subsidiary of the Group’s associated company, Spackman Media Group Limited, also stars in the film. Previously, he also starred in the Disney+ music K-drama, SOUNDTRACK #2 (2023).

The Group believes that Studio Take’s steady flow of film projects, which has been consistently invited to various top local and international film festivals, underscores Studio Take’s capability in delivering top quality content to contribute positively to the Group’s film production performance.


[1] 1KRW: 0.0007USD

Hashtag: #SpackmanEntertainmentGroup

The issuer is solely responsible for the content of this announcement.

About Spackman Entertainment Group Limited

Spackman Entertainment Group Limited (“SEGL” or the “Company“), and together with its subsidiaries, (the “Group“), is one of Korea’s leading entertainment production groups. SEGL is primarily engaged in the independent development, production, presentation, and financing of theatrical motion pictures in Korea.

The Company was founded in 2011 by renowned media and technology investor Charles Spackman who served as the Company’s Executive Chairman until 2017. For the past two decades, Mr. Charles Spackman has been a powerhouse in the Korean entertainment industry starting in the early 2000’s with the pioneering success of Sidus Pictures, the largest movie production company at the time and the first to be listed in Korea. Mr. Spackman is also the Founder, Chairman and Chief Executive Officer of the global investment firm, Spackman Group. For more information, please visit charlesspackman.com and spackman-group.com/charles-spackman.

Since its founding, SEGL had produced more than 30 major motion pictures including a number of the highest grossing and award-winning films in Korea, namely #ALIVE (2020), CRAZY ROMANCE (2019), DEFAULT (2018), MASTER (2016), THE PRIESTS (2015), SNOWPIERCER (2013), COLD EYES (2013) and ALL ABOUT MY WIFE (2012).

Our films are theatrically distributed and released in Korea and overseas markets, as well as for subsequent post-theatrical worldwide release in other forms of media, including online streaming, cable TV, broadcast TV, IPTV, video-on-demand, and home video/DVD, etc. Generally, we release our motion pictures into wide-theatrical exhibition initially in Korea, and then in overseas and ancillary markets.

The Group also invests into and produces Korean television dramas. In addition to our content business, we also own equity stakes in entertainment-related companies and film funds that can financially and strategically complement our existing core operations. SEGL is listed on the Catalist of the Singapore Exchange Securities Trading Limited under the ticker 40E.

Production Labels

SEGL owns a 100% equity interest in Studio Take Co., Ltd. (“Studio Take“) which produced STONE SKIPPING (2020) and THE BOX (2021). One of its films, A MAN OF REASON (2023), premiered in the US at the 42nd Hawaii International Film Festival. The film was also invited to the 47th Toronto International Film Festival, the largest film festival in North America, and the 55th Sitges Film Festival, one of the world’s top three genre film festivals. Produced by Studio Take, the Korean adaptation of the Taiwanese hit YOU ARE THE APPLE OF MY EYE premiered at the Korean theatres on 21 February 2025. The romance film remake originally premiered at the 29th Busan International Film Festival in October 2024. Studio Take shall also release an upcoming film, THE GUEST, which is at the post-production stage and scheduled to be released in the second half of 2025 or in 2026.

The Company owns a 20% equity interest in The Makers Studio Co. Ltd., which plans to produce and release four upcoming films, the first of which will be THE ISLAND OF THE GHOST’S WAIL, a comedy horror film.

Talent Representation

The Company holds an effective shareholding interest of 43.88% in Spackman Media Group Limited (“SMGL“). SMGL, a company incorporated in Hong Kong, together with its subsidiaries, is collectively one of the largest entertainment talent agencies in Korea in terms of the number of artists under management, including some of the top names in the Korean entertainment industry. SMGL operates its talent management business through renowned agencies such as MSteam Entertainment Co., Ltd., SBD Entertainment Inc., UAA&CO Inc. and Play Content Co., Ltd. Through these full-service talent agencies in Korea, SMGL represents and guides the professional careers of a leading roster of award-winning actors/actresses in the practice areas of motion pictures, television, commercial endorsements, and branded entertainment. SMGL leverages its unparalleled portfolio of artists as a platform to develop, produce, finance and own the highest quality of entertainment content projects, including theatrical motion pictures, variety shows and TV dramas. This platform also creates and derives opportunities for SMGL to make strategic investments in development stage businesses that can collaborate with SMGL artists. SMGL is an associated company of the Company. For more information, please visit spackmanmediagroup.com.

For more details, please visit spackmanentertainmentgroup.com.

Media OutReach

Asia’s digital future takes centre stage at Economist Impact’s 5th annual Technology for Change Asia in Hong Kong

Published

on

HONG KONG SAR – Media OuReach Newswire – 24 March 2025 – Economist Impact successfully concluded its 5th annual Technology for Change Asia on March 12th and 13th at the Hopewell Hotel in Hong Kong, bringing together over 570 leaders to explore the transformative power of emerging technologies for business and society.

Photo caption: Albert Wong Hak-keung, chief executive officer of Hong Kong Science & Technology Parks Corporation, Allan Zeman, chairman of Lan Kwai Fong Group, Angel Ng, regional CEO, Greater China of Prudential plc, George Hara, group chairman and CEO of DEFTA Partners and Tom Standage, deputy editor of The Economist, engage in a conversation at Technology for Change Asia.

Taking place in Hong Kong for the 2nd year, the two-day event explored key themes including the future of work in the AI era, the quantum revolution, sustainable tech solutions, human-centered innovation, the Greater Bay Area’s transformation, China’s digital roadmap, smart and green mobility, and ethical AI.

In an opening ministerial keynote address, the Honourable Paul Chan Mo-po, GBM, GBS, MH, JP, Financial Secretary of the Government of the Hong Kong Special Administrative Region, said that Hong Kong, along with the Greater Bay Area, is poised to emerge as a leading international innovation centre because the region is building an ecosystem of patient capital, fostering a pro-innovation environment, and leveraging its unique strengths under the ‘one country, two systems’ arrangement to attract top-tier talent and drive technological progress, including in cutting-edge fields like AI.

Over 70 speakers, including renowned physicist Professor Brian Cox, shared insights on the region’s emerging investment and business opportunities. The event highlighted the unique position of the Greater Bay Area in using technology for business impact, and featured discussions on how businesses and governments can prioritise the human element in technology research and adoption to close the digital divide.

The event featured speakers from leading organisations including Alibaba.com, Booking.com, Deutsche Bank, DHL, Google, HSBC, IBM, JLL, Klook, Lan Kwai Fong Group, Li & Fung, Li Auto, LinkedIn, Mercedes-Benz Group, OCBC, Swire Hotels Group, Tencent Quantum Lab, Uber, and WhatsApp, and many more.

“From quantum computing to ethical AI, Technology for Change Asia tackled the innovations defining our future,” said Charles Ross, principal, technology and society, Asia-Pacific at Economist Impact. “The conversations we had were not just about technology but about shaping a more resilient and equitable world.”

The 5th annual Technology for Change Asia was sponsored by the Kellogg-HKUST Executive MBA Program, Hong Kong Science & Technology Parks Corporation, Tata Communications, IBM, AIA and McKinsey Global Institute. The event was supported by Brand Hong Kong, The Hong Kong Tourism Board, AI Club Asia, Asia MarTech Society, and the British Consulate-General Hong Kong. The official travel partner was Cathay Pacific.

For more information about Technology for Change Asia, please visit http://econimpact.co/TFCpress
Hashtag: #EconomistImpact

The issuer is solely responsible for the content of this announcement.

About Economist Impact

Economist Impact empowers businesses, governments and foundations to catalyse change and enable progress. Uniting the expertise The Economist Group is known for under a single brand, Economist Impact brings together policy research and insights, data visualisation, custom storytelling, events and media. Economist Impact combines the rigour of a think tank with the creativity of a media brand, engaging an influential audience in the areas of sustainability, healthcare and new globalisation. Visit for more information.

Continue Reading

Media OutReach

VinFuture Prize empowered the woman scientist Dr. Firdausi Qadri to give back to Bangladesh

Published

on

HANOI, VIETNAM – Media OutReach Neswire – 24 March 2025 – A leading force in cholera vaccine research, Dr. Firdausi Qadri at the International Centre for Diarrheal Disease Research, Bangladesh (icddr,b) has dedicated her career to combating this dramatic mortal disease through the innovative improvement of oral cholera vaccination, aiming to large-scale vaccination effort in developing countries.

Sharing with the VinFuture Foundation, Dr. Qadri reflects on her groundbreaking work and her passion for expanding STEM education for women. In the face of societal barriers, particularly in Bangladesh, she remains committed to empowering women in science and using her VinFuture Prize value to strengthen the country’s scientific community.

The ongoing battle against cholera

Having established herself as one of the scientific titans in the vaccine area, Dr. Qadri has developed a single oral dose of an affordable cholera vaccine to address the public health needs in Bangladesh. Her research opens the possibility of large-scale vaccination campaigns in poor countries to prevent outbreaks and reduce the healthcare cost burden, allowing them to invest in education and economic activities. This revolutionizing discovery has earned her global recognition, including the 2024 VinFuture Special Prize for Innovators from Developing Countries.

The VinFuture Prize was completely unexpected, but it has given me immense energy and a profound sense of purpose to turn scientific solutions into real-world applications that benefit those in adverse settings, including humanitarian crises globally,” Dr. Qadri said.

Beyond its personal significance, the VinFuture Prize also empowered Dr. Qadri to give back to her home country. In 2014, Dr. Qadri formed a non-profit research institution called the ideSHi (Institute for Developing Science and Health Initiatives) located on the 11th floor of Blue Moon Gram Tower in ECB Chattar, Dhaka. She shared an astounding initiative to expand this institute using the 500,000 USD prize value from VinFuture, “Together with the VinFuture Prize money and a quarter of my personal funds, I took a bold step forward, acquiring an additional 5,000 square feet of space within the same building as ideSHi’s original facility,” she elaborated.

This facility is a bold initiative dedicated to improving public health and nurturing the next generation of scientists. Since then, this institute provides state-of-the-art facilities, offers training programs, collaborates with international partners, conducts research on genetic diseases including thalassemia – the most common blood disorder in Bangladesh – as well as infectious diseases.

Over the past decade, ideSHi has expanded tremendously, and this new extension will allow us to tackle even more critical health challenges while further strengthening scientific capacity in Bangladesh,” she shared. “With prize money received from VinFuture, I am confident that this support will help ideSHi develop pragmatic solutions to public health challenges and ultimately help advance Bangladesh’s position in biomedical research.”

The achievement results in her determination after witnessing firsthand the dire impact of cholera and diarrheal diseases. Her journey began as a scientist with a deep passion for immunology, later on extended her work beyond the laboratory to the field, fully devoted to the cause of uplifting the lives of Bangladesh and beyond.

However, through her extensive work in diarrheal diseases at their main hospital in Bangladesh, Dr. Qadri estimates an annual intake of approximately 200,000 patients, with 90-95% comes from impoverished backgrounds. Living in overcrowded conditions with shared toilets, kitchens, and bathrooms, they face rapid disease transmission. “If one person contracts cholera, the infection can spread to three other people in the family and beyond due to contaminated hands and food,” Dr. Qadri explained. “It’s very difficult to control.”

Recognizing the persistent devastation of global health crises, Dr. Qadri extended her research beyond the laboratory. She conducted field studies on vaccine effectiveness, distribution strategies, and public health interventions. Her efforts extended beyond academia as she worked more with the government, advocating for necessary actions to improve healthcare access.

Over 15 to 20 years, my work has evolved to encompass not just vaccine development, but also implementation strategies – exploring the effectiveness of different modes in delivering vaccines and understanding how to integrate water, sanitation, and hygiene (WASH) with vaccination programs to achieve cholera control,” she noted.

Dr. Qadri emphasized that cholera remains a disease of poverty, often overlooked due to its association with inadequate sanitation and clean water access. She also pointed out that some governments were reluctant to acknowledge the disease’s prevalence, fearing for their global image. Therefore, she expressed deep gratitude and immense joy at being recognized by such a prestigious global award as the VinFuture Prize. “This recognition is a tremendous honor and serves as a motivation for me to move ahead,” she shared.

Breaking glass ceilings

Dr. Qadri’s dedication to rigorous scientific research and her success in the cholera vaccine area serves as an inspiration for young women all over the world. However, ​​for women in science, particularly in developing countries across Asia, the road is often fraught with challenges. Deep-seated prejudices and invisible glass ceilings make it difficult for women to gain recognition in male-dominated fields.

I always want to be known as a scientist, not a “woman scientist,” who works alongside men as equals“, Dr. Qadri shared. “But I cannot deny that acceptance has not always come easily.”

The unwavering support of her family played a crucial role, encouraging her to push boundaries and proving that a woman is just as capable as a man. “I traveled to remote areas, worked long hours in the field, and committed myself fully to scientific research. I have managed to overcome many prejudices, though challenges remain,” she noted.

It is also a driving force that motivates her to passionately advocate for empowering women in STEM education. According to her, science, technology, engineering, and mathematics are the foundation of progress, driving innovation and shaping the future. Yet, women remain underrepresented in STEM fields, not only in developing countries but even in advanced economies.

If we truly want to make a meaningful contribution to the world, women must be part of this transformation,” Dr. Qadri emphasized.

Many hesitate to pursue careers in STEM, not due to a lack of ability but because of societal expectations and deeply ingrained biases. Fields including engineering and mathematics, in particular, remain male-dominated, with cultural norms dictating which professions are deemed “suitable” for women.

Another critical factor is the cost and commitment required. STEM education is more demanding, expensive, and time-intensive compared to fields including finance or commerce. Success in STEM requires years of dedication and persistence, making it an uphill battle, especially for women who must balance professional ambitions with societal expectations of family life.

I try to use my journey to show young women that it is possible to have a family, raise children, and do science.” She remarked, “You just need to know the mechanism to do it. There is no secret formula: just focus, perseverance, and unwavering commitment to the work you choose to do.”

Addressing health disparities

Driven by the goal to seek effective preventive public health solutions for Bangladesh and other developing countries, Dr. Qadri focuses on large-scale clinical studies using Vietnamese live vaccine train, which allowed her to conclude the benefit, power and feasibility of an oral dose of an affordable vaccine.

Vietnam, which has been able to control cholera better through concerted public health efforts, has always been an example I reflected on.” She stated, “If Vietnam can better control cholera through a comprehensive public health approach, why can’t we?”

Besides vaccination, the scientific titan emphasized the need for a holistic approach, including improvements in WASH education, and surveillance. However, behavioral change and access to clean water remain significant hurdles. Thus, according to Dr. Qadri, to provide crucial protection in the short term, there are two key strategies: reactive vaccination during an outbreak and preventive vaccination to build immunity.

However, a major obstacle the world faces is the global shortage of cholera vaccines. “Despite cholera affecting millions across Asia, Africa, and Latin America, only 80 million vaccine doses are currently available annually. This is far below what is needed – Bangladesh alone requires 100 million doses in the coming years,” she noted.

The economic constraints surrounding cholera vaccines also present a challenge. Since cholera is often considered a “disease of poverty,” many pharmaceutical companies hesitate to invest in its production due to low profit margins. “This is already happening,” she stressed.

To address this, Dr. Qadri actively advocates for increased vaccine production in Bangladesh. She shared that one of her team’s key achievements has been demonstrating that in a major outbreak, giving the vaccine in a reactive way can quickly reduce the number of cases. “We have implemented this strategy in multiple regions of Bangladesh,” Dr. Qadri added.

More importantly, as a result of our dedication, we now have a national cholera control plan, centered on preventive vaccination, ensuring that people receive doses regularly – whether annually or every three years – to stay protected before outbreaks occur. This is a significant milestone in our fight against the disease.” she said.
Hashtag: #VinFuture

The issuer is solely responsible for the content of this announcement.

VinFuture

The VinFuture Foundation, established on International Human Solidarity Day on December 20th, 2020, is a non-profit organization co-founded by billionaire Mr. Pham Nhat Vuong and his wife, Mrs. Pham Thu Huong. The Foundation’s core activity is awarding the annual VinFuture Prize, which recognizes transformative scientific and technological innovations capable of making significant positive changes in the lives of millions of people worldwide.

The nomination period for the 2025 VinFuture Prize will close at 2:00 PM on April 17, 2025 (Vietnam time, GMT+7).

The VinFuture Prize consists of four prestigious awards presented each year. The most esteemed is the VinFuture Grand Prize, valued at US$3 million, making it one of the largest annual prizes globally. Additionally, there are three Special Prizes, each valued at US$500,000, specifically dedicated to honoring women innovators, innovators from developing countries, and innovators with outstanding achievements in emerging fields.

Continue Reading

Media OutReach

HOFA Gallery and PhillipsX Presents SPACES II: Capturing the Ephemera at Phillips’ Asia Headquarters in Hong Kong’s West Kowloon Cultural District

Published

on

Exploring art, technology and impermanence at Phillips during Hong Kong Art Week 2025, featuring seven visionary artists: Refik Anadol, Sougwen Chung, Random International, Tyler Hobbs, Addie Wagenknecht, Gina Choy & Maja Petrić

HONG KONG SAR – Media OutReach Neswire – 24 March 2025 – SPACES II: Capturing the Ephemera, presented by HOFA Gallery and PhillipsX, explores new artistic and technological frontiers, expanding on the themes introduced in the inaugural SPACES exhibition in London during Frieze Week 2024. This latest instalment, taking place during Hong Kong Art Week 2025, reflects further on the intersection of art, technology and impermanence.

Featuring works by seven visionary artists; Refik Anadol, Sougwen Chung, Random International, Tyler Hobbs, Addie Wagenknecht, Gina Choy and Maja Petrić, the selling exhibition examines how technology can capture, preserve and transform fleeting moments into enduring artistic expressions. It runs from 28 March to 15 April 2025 at Phillips’ Asia headquarters in Hong Kong’s West Kowloon Cultural District.

Sougwen Chung 'Body Machine (Meridians) - Glacial Biome series, 2025. (Courtesy of the Artist & HOFA)

SPACES is an innovative series of exhibitions that confronts the profound challenges and possibilities presented by computing technologies and their impact on human experience. The first edition, launched at Phillips London in 2024, explored the dynamic interplay between AI, generative art and digital creativity.

SPACES II examines how technology can give form to the impermanent, whether through environmental shifts, generative processes, or the fluidity of human perception and memory. The selling exhibition will showcases a diverse array of works, including immersive installations, generative digital art, algorithmic designs and contemporary mixed-media pieces.

Miety Heiden, Deputy Chairwoman and Head of Private Sales at Phillips, says: “Following the success of the first installment in London in 2024, we are thrilled to bring SPACES II: Capturing the Ephemera to Phillips Hong Kong in collaboration with HOFA Gallery. This exhibition continues our commitment to showcasing artists at the forefront of digital and generative art, exploring how technology transforms transient moments into lasting expressions. As part of Hong Kong Art Week 2025, we look forward to presenting these groundbreaking works to a global audience in our Asia headquarters.”

SPACES II: Capturing the Ephemera: Free and open to the public daily.
Dates: 27 March VIP & Press Preview. 28 March to 15 April 2025 (Closed on 4 April)
28-30 March 11:00-19:00
1-15 April 10:00-18:00
Venue: Phillips Asia Headquarters, 1F, WKCDA Tower, West Kowloon Cultural District, 8 Austin Road West, Kowloon
TheHouseofFineArt.com & Exhibitions.Phillips.com
Hashtag: #HOFAGallery #PhillipsX

The issuer is solely responsible for the content of this announcement.

Continue Reading

Trending